HRP20180774T1 - Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom - Google Patents
Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom Download PDFInfo
- Publication number
- HRP20180774T1 HRP20180774T1 HRP20180774TT HRP20180774T HRP20180774T1 HR P20180774 T1 HRP20180774 T1 HR P20180774T1 HR P20180774T T HRP20180774T T HR P20180774TT HR P20180774 T HRP20180774 T HR P20180774T HR P20180774 T1 HRP20180774 T1 HR P20180774T1
- Authority
- HR
- Croatia
- Prior art keywords
- preparation
- desmopressin
- use according
- patient
- treatment
- Prior art date
Links
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 title claims 16
- 229960004281 desmopressin Drugs 0.000 title claims 14
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 title claims 14
- 206010029446 nocturia Diseases 0.000 title claims 7
- 230000007958 sleep Effects 0.000 title claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 239000012458 free base Substances 0.000 claims 5
- 210000002700 urine Anatomy 0.000 claims 5
- FIEYHAAMDAPVCH-UHFFFAOYSA-N 2-methyl-1h-quinazolin-4-one Chemical class C1=CC=C2NC(C)=NC(=O)C2=C1 FIEYHAAMDAPVCH-UHFFFAOYSA-N 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 230000000422 nocturnal effect Effects 0.000 claims 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- 235000015165 citric acid Nutrition 0.000 claims 2
- 229960002845 desmopressin acetate Drugs 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Claims (18)
1. Pripravak, koji sadrži dezmopresin za uporabu kod liječenja muškog pacijenta koji ima nokturiju ili noćnu poliuriju, za smanjenje broja noćnih pražnjenja mjehura kod muškog pacijenta, koji treba takvo liječenje, te pripravak sadrži orodisperzibilnu dozu dezmopresina od 25 µg, naznačen time da se doza mjeri kao slobodna baza dezmopresina, za administraciju prije počinka.
2. Pripravak, koji sadrži dezmopresin za uporabu kod liječenja muškog pacijenta, koji ima nokturiju ili noćnu poliuriju, za smanjenje noćnog volumena urina kod muškog pacijenta, koji treba takvo liječenje, te pripravak sadrži orodisperzibilnu dozu dezmopresina od 25 µg, naznačen time da se doza mjeri kao slobodna baza dezmopresina, za administraciju prije počinka.
3. Pripravak za uporabu prema zahtjevu 1 ili 2, naznačen time da se doza uzima od 0,8 do 3 sata prije spavanja pacijenta; i/ili pri čemu se doza uzima jednom dnevno.
4. Pripravak za uporabu prema zahtjevu 1-3, naznačen time da je doza slobodne baze dezmopresina u obliku acetatne soli dezmopresina.
5. Pripravak za uporabu prema zahtjevu 1-3, naznačen time da je orodisperzibilna doza dezmopresina u obliku doziranja, koji sadrži acetat dezmopresina, želatinu, manitol i limunsku kiselinu.
6. Pripravak za uporabu prema zahtjevu 1-5, naznačen time da se liječenje odvija tijekom razdoblja liječenja.
7. Pripravak za uporabu prema zahtjevu 1-5, naznačen time da je razdoblje liječenja barem 28 dana.
8. Pripravak za uporabu prema zahtjevu 1-7, naznačen time da pacijent ima stopu proizvodnje urina tijekom spavanja veću od prosječne stope cjelodnevne proizvodnje urina pacijenta.
9. Pripravak za uporabu prema zahtjevu 1-8, naznačen time da je pacijent stariji od 65 godina.
10. Pripravak za uporabu prema zahtjevu 9, naznačen time da pacijent ima razinu natrija u serumu barem 135 mmol/L nakon administracije.
11. Pripravak, koji sadrži dezmopresin za uporabu kod liječenja ženskog pacijenta, koji ima nokturiju ili noćnu poliuriju, za smanjenje broja noćnih pražnjenja mjehura kod ženskog pacijenta, koji treba takvo liječenje, te pripravak sadrži orodisperzibilnu dozu dezmopresina od 10 µg za administraciju prije počinka, naznačen time da se doza mjeri kao slobodna baza dezmopresina.
12. Pripravak za uporabu prema zahtjevu 11 za liječenje ženskog pacijenta starijeg od 50 godina.
13. Pripravak za uporabu prema zahtjevu 11 za liječenje ženskog pacijenta starijeg od 65 godina.
14. Pripravak za uporabu prema zahtjevu 11-13, naznačen time da je doza slobodne baze dezmopresina u obliku acetatne soli dezmopresina.
15. Pripravak za uporabu prema zahtjevu 11-13, naznačen time da je orodisperzibilna doza dezmopresina u obliku doziranja, koji sadrži acetat dezmopresina, želatinu, manitol i limunsku kiselinu.
16. Pripravak za uporabu prema zahtjevu 11-15, naznačen time da se liječenje odvija tijekom razdoblja liječenja.
17. Pripravak za uporabu prema zahtjevu 11-15, naznačen time da je razdoblje liječenja barem 28 dana.
18. Pripravak za uporabu prema zahtjevu 11, naznačen time da pacijent ima stopu proizvodnje urina tijekom spavanja veću od prosječne stope cjelodnevne proizvodnje urina pacijenta.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5512008P | 2008-05-21 | 2008-05-21 | |
EP16165875.2A EP3085381B1 (en) | 2008-05-21 | 2009-05-21 | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20180774T1 true HRP20180774T1 (hr) | 2018-08-10 |
Family
ID=41100519
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20161066TT HRP20161066T1 (hr) | 2008-05-21 | 2016-08-22 | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom |
HRP20180774TT HRP20180774T1 (hr) | 2008-05-21 | 2018-05-17 | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom |
HRP20190114TT HRP20190114T1 (hr) | 2008-05-21 | 2019-01-18 | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom |
HRP20191854TT HRP20191854T1 (hr) | 2008-05-21 | 2019-10-14 | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20161066TT HRP20161066T1 (hr) | 2008-05-21 | 2016-08-22 | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20190114TT HRP20190114T1 (hr) | 2008-05-21 | 2019-01-18 | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom |
HRP20191854TT HRP20191854T1 (hr) | 2008-05-21 | 2019-10-14 | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom |
Country Status (16)
Country | Link |
---|---|
US (2) | US9974826B2 (hr) |
EP (5) | EP3225250B1 (hr) |
JP (5) | JP5767103B2 (hr) |
CA (1) | CA2724653A1 (hr) |
DK (5) | DK3225249T3 (hr) |
ES (5) | ES2462465T5 (hr) |
HR (4) | HRP20161066T1 (hr) |
HU (5) | HUE039013T4 (hr) |
LT (5) | LT3225250T (hr) |
LU (1) | LUC00015I2 (hr) |
NO (3) | NO2296686T3 (hr) |
PL (5) | PL3085381T3 (hr) |
PT (5) | PT3225249T (hr) |
SI (4) | SI2712622T1 (hr) |
TR (2) | TR201807224T4 (hr) |
WO (1) | WO2009143356A1 (hr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO2296686T3 (hr) * | 2008-05-21 | 2014-07-12 | ||
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100286045A1 (en) * | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
WO2015063602A1 (en) * | 2013-10-29 | 2015-05-07 | Ferring B.V. | Desmopressin and blood glucose |
KR20210078500A (ko) * | 2018-10-17 | 2021-06-28 | 닛뽕 케미파 가부시키가이샤 | 야간 다뇨의 치료 또는 예방제 |
AU2021257176A1 (en) * | 2020-04-14 | 2022-11-10 | Nippon Chemiphar Co., Ltd. | Sleep quality improver |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH495957A (de) | 1966-09-15 | 1970-09-15 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids |
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4285858A (en) * | 1979-10-30 | 1981-08-25 | Mt. Sinai School Of Medicine Of The City University Of N.Y. | Vasopressin analogs |
US4263283A (en) * | 1980-05-16 | 1981-04-21 | Ferring Pharmaceuticals, Inc. | Method for prophylaxis and/or treatment of sickle cell disease |
GB2111423B (en) | 1981-12-02 | 1985-06-26 | Wyeth John & Brother Ltd | Making quick-dissolving pills |
ATE24964T1 (de) | 1981-12-11 | 1987-01-15 | Wyeth John & Brother Ltd | Verfahren zur herstellung von festen formgegenstaenden. |
US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
SE8306367L (sv) | 1983-11-18 | 1985-05-19 | Ferring Ab | Antidiuretiskt verkande farmaceutiskt preparat |
US4863737A (en) | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
IE60941B1 (en) | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
US4878892A (en) | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
US4783450A (en) | 1987-04-13 | 1988-11-08 | Warner-Lambert Company | Use of commercial lecithin as skin penetration enhancer |
DK365389D0 (da) | 1989-07-24 | 1989-07-24 | Fertin Lab As | Antifungalt tyggegummipraeparat |
US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
TW279133B (hr) | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
US5527288A (en) * | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
SE9101022D0 (sv) * | 1991-01-09 | 1991-04-08 | Paal Svedman | Medicinsk suganordning |
US6746678B1 (en) * | 1991-02-22 | 2004-06-08 | Howard K. Shapiro | Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
CA2070061C (en) | 1991-06-07 | 2004-02-10 | Shigeyuki Takama | Physiologically active polypeptide-containing pharmaceutical composition |
AU669856B2 (en) | 1991-08-26 | 1996-06-27 | Abbott Laboratories | Compositions and methods for the sublingual or buccal administration of therapeutic agents |
DE69227467T2 (de) | 1991-12-24 | 1999-04-22 | Yamanouchi Pharma Co Ltd | Intrabukkal desintegrierende zubereitung und ihre herstellung |
US5298256A (en) * | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
US5534496A (en) * | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
CA2090738C (en) | 1993-02-24 | 1996-05-21 | Hema-Quebec | Use of paf |
SE9300937L (sv) * | 1993-03-19 | 1994-09-20 | Anne Fjellestad Paulsen | Komposition för oral administrering av peptider |
US5434121A (en) * | 1993-03-25 | 1995-07-18 | Mitsui Toatsu Chemicals, Incorporated | Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same |
SE501677C2 (sv) | 1993-06-18 | 1995-04-10 | Ferring Bv | Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel |
US5674850A (en) | 1993-12-23 | 1997-10-07 | Ferring Ab | High purity desmopressin produced in large single batches |
US5482931A (en) * | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
US5500413A (en) * | 1993-06-29 | 1996-03-19 | Ferring Ab | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
DE69427820T2 (de) | 1993-06-29 | 2001-11-08 | Ferring Bv | Zusammensetzungen zur nasalen verabreichung von desmopressin |
EP0710243B1 (en) | 1993-06-29 | 2000-06-14 | Ferring B.V. | Synthesis of cyclic peptides |
US5985835A (en) | 1993-12-23 | 1999-11-16 | Ferring B.V. | Desmopressin for nocturia, incontinence and enuresis |
US5707648A (en) * | 1993-11-17 | 1998-01-13 | Lds Technologies, Inc. | Transparent liquid for encapsulated drug delivery |
SE9400918L (sv) * | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
JP2551742B2 (ja) * | 1994-05-23 | 1996-11-06 | 三星電機株式会社 | 医薬品投与用皮膚傷形成装置 |
DE4424800A1 (de) * | 1994-07-14 | 1996-01-18 | Philips Patentverwaltung | Schaltungsanordnung zum Liefern von Speisespannungen |
SE518619C2 (sv) * | 1994-12-09 | 2002-10-29 | Gs Dev Ab | Komposition för reglerad frisättning innehållande monokaproin |
GB9502879D0 (en) * | 1995-02-14 | 1995-04-05 | Oxford Biosciences Ltd | Particle delivery |
IL113459A (en) * | 1995-04-23 | 2000-07-16 | Electromagnetic Bracing System | Electrophoretic cuff apparatus |
US5843016A (en) | 1996-03-18 | 1998-12-01 | Physion S.R.L. | Electromotive drug administration for treatment of acute urinary outflow obstruction |
TW411277B (en) | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
GB9612629D0 (en) | 1996-06-17 | 1996-08-21 | Oxford Biosciences Ltd | Method for providing dense particle compositions for use in transdermal particle delivery |
JP4012252B2 (ja) * | 1996-06-18 | 2007-11-21 | アルザ コーポレイション | 薬剤の経皮放出又はサンプリングを高めるための装置 |
US5763398A (en) * | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
US5922680A (en) * | 1996-10-23 | 1999-07-13 | Ferring, B.V. | Stabilized composition for oral administration of peptides |
SE9604341D0 (sv) | 1996-11-26 | 1996-11-26 | Ferring Bv | Hepta-peptide oxytocin analogue |
FR2758195B1 (fr) | 1997-01-09 | 1999-02-26 | Sgs Thomson Microelectronics | Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele |
US5821230A (en) | 1997-04-11 | 1998-10-13 | Ferring Bv | GnRH antagonist decapeptides |
US6511974B1 (en) * | 1997-07-30 | 2003-01-28 | Wyeth | Tricyclic vasopressin agonists |
US6194407B1 (en) * | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
US5932745A (en) * | 1997-07-30 | 1999-08-03 | American Home Products Corporation | Process for converting propargylic amine-N-oxides to enaminones |
US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
US7153845B2 (en) | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US6322532B1 (en) | 1998-06-24 | 2001-11-27 | 3M Innovative Properties Company | Sonophoresis method and apparatus |
US7138393B2 (en) * | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
US6148232A (en) | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
GB9827292D0 (en) | 1998-12-12 | 1999-02-03 | Univ Strathclyde | Freeze drying |
US6406455B1 (en) * | 1998-12-18 | 2002-06-18 | Biovalve Technologies, Inc. | Injection devices |
US20060025387A1 (en) * | 1998-12-23 | 2006-02-02 | Cytoscan Sciences Llc | Compositions and methods for the treatment of disorders of the central and peripheral nervous systems |
GB9901819D0 (en) | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
US6620807B1 (en) | 1999-02-04 | 2003-09-16 | Wyeth | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
US6235900B1 (en) * | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
US6344451B1 (en) * | 1999-02-04 | 2002-02-05 | American Home Products | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
ATE283708T1 (de) | 1999-02-15 | 2004-12-15 | Sumitomo Pharma | Im mundraum schnellzerfallende tabletten |
WO2000048669A1 (en) | 1999-02-18 | 2000-08-24 | Biovalve Technologies, Inc. | Electroactive pore |
AR014640A1 (es) * | 1999-02-23 | 2001-03-28 | Univ Nac Quilmes | UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE. |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US7060708B2 (en) * | 1999-03-10 | 2006-06-13 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
US6210699B1 (en) | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
GB2355454A (en) | 1999-10-20 | 2001-04-25 | Ferring Bv | Antidiuretic agents |
US6558695B2 (en) * | 1999-12-16 | 2003-05-06 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers |
GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
CA2396569C (en) | 2000-01-07 | 2010-03-23 | Biovalve Technologies, Inc. | Injection device |
US20070032410A1 (en) * | 2000-01-11 | 2007-02-08 | Atossa Healthcare, Inc. | Compositions and methods for the treatment of psychiatric disorders |
AT409081B (de) | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
GB0015601D0 (en) * | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
US6348486B1 (en) * | 2000-10-17 | 2002-02-19 | American Home Products Corporation | Methods for modulating bladder function |
JP4659336B2 (ja) | 2000-10-26 | 2011-03-30 | アルザ・コーポレーシヨン | 被覆された微細突出物を有する経皮的薬剤配達装置 |
US7931614B2 (en) | 2000-11-30 | 2011-04-26 | Valeritas, Inc. | Injection systems |
ES2717656T3 (es) * | 2000-11-30 | 2019-06-24 | Valeritas Inc | Dispositivo con microsonda amovible sustancialmente libre sobre el alojamiento |
EP1345646A2 (en) | 2000-12-14 | 2003-09-24 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
US7027478B2 (en) * | 2000-12-21 | 2006-04-11 | Biovalve Technologies, Inc. | Microneedle array systems |
JP5354763B2 (ja) | 2001-03-16 | 2013-11-27 | アルザ・コーポレーシヨン | フェンタニルを投与するための経皮的張り付け剤 |
DK1381608T3 (da) * | 2001-04-12 | 2008-02-04 | Wyeth Corp | Cyclohexylphenylvasopressinagonister |
US7022699B2 (en) * | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
ES2282423T3 (es) * | 2001-04-12 | 2007-10-16 | Wyeth | Azepinas y diazepinas bi- y triciclicas n-bifenilcarbonil- y n-fenilpiridilcarbonil sustituidas como agonistas de la vasopresina. |
US7615234B2 (en) * | 2001-09-11 | 2009-11-10 | Glide Pharmaceutical Technologies Limited | Drug delivery technology |
MXPA04002449A (es) | 2001-09-13 | 2004-07-23 | Kissei Pharmaceutical | Cristales de derivado de hidroxinorefedrina. |
US6723077B2 (en) * | 2001-09-28 | 2004-04-20 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
US6893655B2 (en) * | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
KR100632882B1 (ko) * | 2001-11-16 | 2006-10-13 | 아스텔라스세이야쿠 가부시키가이샤 | 4, 4-디플루오로-1, 2, 3,4-테트라하이드로-5h-1-벤즈아제핀 유도체 또는 그 염 |
DE60307082D1 (de) * | 2002-05-07 | 2006-09-07 | Ferring Bv | In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US6945952B2 (en) | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
GB2421689B (en) * | 2002-08-05 | 2007-03-07 | Caretek Medical Ltd | Drug delivery system |
WO2004030743A2 (en) * | 2002-09-30 | 2004-04-15 | Alza Corporation | Drug delivery device having coated microprojections incorporating vasoconstrictors |
NZ539199A (en) * | 2002-10-09 | 2008-09-26 | Toray Industries | Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
US7383084B2 (en) * | 2002-10-31 | 2008-06-03 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
EP1428526A1 (en) | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
DE10259934B3 (de) * | 2002-12-20 | 2004-10-14 | H.C. Starck Gmbh | Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile |
AR042815A1 (es) * | 2002-12-26 | 2005-07-06 | Alza Corp | Dispositivo de suministro de agente activo que tiene miembros compuestos |
EP1619185B1 (en) * | 2003-04-28 | 2011-06-15 | Astellas Pharma Inc. | 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
US20060193825A1 (en) * | 2003-04-29 | 2006-08-31 | Praecis Phamaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
US7094545B2 (en) | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
KR20060029162A (ko) | 2003-06-30 | 2006-04-04 | 알자 코포레이션 | 피부 피어싱 미세돌출부를 코팅하는 방법 |
CN1826099B (zh) | 2003-07-25 | 2010-06-09 | 凡林有限公司 | 固体剂型药物组合物及其制造方法 |
EP1500390B1 (en) * | 2003-07-25 | 2005-08-17 | Ferring B.V. | Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof |
US6930932B2 (en) * | 2003-08-27 | 2005-08-16 | Hewlett-Packard Development Company, L.P. | Data signal reception latch control using clock aligned relative to strobe signal |
EP1675539A4 (en) * | 2003-10-24 | 2007-09-12 | Alza Corp | METHOD AND SYSTEM FOR PRETREATMENT FOR IMPROVING TRANSDERMAL DRUG DELIVERY |
JP2007508914A (ja) | 2003-10-24 | 2007-04-12 | アルザ・コーポレーシヨン | 経皮薬剤送達を促進するための装置及び方法 |
JP4682144B2 (ja) * | 2003-10-31 | 2011-05-11 | アルザ・コーポレーシヨン | 微小突起列のための自己−作動性アプリケーター |
CA2545194C (en) * | 2003-11-10 | 2014-10-21 | Seymour H. Fein | Pharmaceutical compositions including low dosages of desmopressin |
EP1530967B1 (en) | 2003-11-13 | 2006-05-03 | Ferring B.V. | Blister pack and solid dosage form comprising desmopressin |
US7018653B2 (en) * | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
PT1550439E (pt) | 2003-12-29 | 2006-06-30 | Ferring Bv | Metodo para a preparacao de uma forma solida de dosagem de desmopressina |
CA2552754A1 (en) * | 2004-01-09 | 2005-08-04 | Alza Corporation | Frequency assisted transdermal agent delivery method and system |
WO2006029411A2 (en) * | 2004-09-09 | 2006-03-16 | Yeda Research And Development Co. Ltd. | Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
US7097776B2 (en) * | 2004-10-22 | 2006-08-29 | Hewlett-Packard Development Company, L.P. | Method of fabricating microneedles |
US20060093658A1 (en) * | 2004-10-26 | 2006-05-04 | Gayatri Sathyan | Apparatus and method for transdermal delivery of desmopressin |
CN100339081C (zh) | 2004-11-10 | 2007-09-26 | 范敏华 | 一种氯雷他定口腔崩解片剂的制备方法 |
US7180274B2 (en) * | 2004-12-10 | 2007-02-20 | Aimtron Technology Corp. | Switching voltage regulator operating without a discontinuous mode |
CA2605554A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
PE20061298A1 (es) | 2005-04-22 | 2006-12-24 | Wyeth Corp | Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c |
CN101203216A (zh) | 2005-04-22 | 2008-06-18 | 惠氏公司 | 二氢苯并呋喃衍生物及其用途 |
JP2008538575A (ja) | 2005-04-22 | 2008-10-30 | ワイス | ベンゾジオキサンおよびベンゾジオキソラン誘導体ならびにそれらの使用 |
AR056320A1 (es) | 2005-04-22 | 2007-10-03 | Wyeth Corp | Derivados de cromano y cromeno, procesos de obtencion, composiciones farmaceuticas y usos de los mismos |
US7856263B2 (en) | 2005-04-22 | 2010-12-21 | Travanti Pharma Inc. | Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis |
EP1874292A2 (en) | 2005-04-24 | 2008-01-09 | Wyeth | Methods for modulating bladder function |
WO2006138719A2 (en) | 2005-06-17 | 2006-12-28 | Georgia Tech Research Corporation | Coated microstructures and method of manufacture thereof |
WO2007002523A2 (en) | 2005-06-24 | 2007-01-04 | 3M Innovative Properties Company | Collapsible patch with microneedle array |
WO2007083323A2 (en) | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
WO2007098945A2 (en) | 2006-03-02 | 2007-09-07 | Ferring International Center S.A. | Stable solid dosage form comprising desmopressin |
WO2007127976A2 (en) | 2006-05-01 | 2007-11-08 | Georgia Tech Research Corporation | Particle based molding |
EP2197532A1 (en) | 2007-08-06 | 2010-06-23 | Serenity Pharmaceuticals Corporation | Methods and devices for desmopressin drug delivery |
NO2296686T3 (hr) * | 2008-05-21 | 2014-07-12 |
-
2009
- 2009-05-21 NO NO09751584A patent/NO2296686T3/no unknown
- 2009-05-21 SI SI200931494A patent/SI2712622T1/sl unknown
- 2009-05-21 LT LT17171155T patent/LT3225250T/lt unknown
- 2009-05-21 SI SI200932000T patent/SI3225250T1/sl unknown
- 2009-05-21 LT LTEP16165875.2T patent/LT3085381T/lt unknown
- 2009-05-21 WO PCT/US2009/044860 patent/WO2009143356A1/en active Application Filing
- 2009-05-21 LT LTEP17171152.6T patent/LT3225249T/lt unknown
- 2009-05-21 EP EP17171155.9A patent/EP3225250B1/en active Active
- 2009-05-21 SI SI200931838T patent/SI3085381T1/en unknown
- 2009-05-21 DK DK17171152.6T patent/DK3225249T3/en active
- 2009-05-21 HU HUE16165875A patent/HUE039013T4/hu unknown
- 2009-05-21 PL PL16165875T patent/PL3085381T3/pl unknown
- 2009-05-21 DK DK16165875.2T patent/DK3085381T3/en active
- 2009-05-21 HU HUE17171155A patent/HUE046050T2/hu unknown
- 2009-05-21 NO NO16165875A patent/NO3085381T3/no unknown
- 2009-05-21 PL PL09751584T patent/PL2296686T5/pl unknown
- 2009-05-21 CA CA2724653A patent/CA2724653A1/en not_active Abandoned
- 2009-05-21 TR TR2018/07224T patent/TR201807224T4/tr unknown
- 2009-05-21 PT PT17171152T patent/PT3225249T/pt unknown
- 2009-05-21 DK DK17171155T patent/DK3225250T3/da active
- 2009-05-21 ES ES09751584.5T patent/ES2462465T5/es active Active
- 2009-05-21 JP JP2011510705A patent/JP5767103B2/ja active Active
- 2009-05-21 ES ES13181216.6T patent/ES2596435T3/es active Active
- 2009-05-21 SI SI200931912T patent/SI3225249T1/sl unknown
- 2009-05-21 TR TR2018/19189T patent/TR201819189T4/tr unknown
- 2009-05-21 ES ES16165875.2T patent/ES2677548T3/es active Active
- 2009-05-21 PT PT131812166T patent/PT2712622T/pt unknown
- 2009-05-21 US US12/469,801 patent/US9974826B2/en active Active
- 2009-05-21 ES ES17171155T patent/ES2756706T3/es active Active
- 2009-05-21 PL PL17171152T patent/PL3225249T3/pl unknown
- 2009-05-21 PL PL13181216T patent/PL2712622T3/pl unknown
- 2009-05-21 PL PL17171155T patent/PL3225250T3/pl unknown
- 2009-05-21 EP EP13181216.6A patent/EP2712622B1/en active Active
- 2009-05-21 PT PT97515845T patent/PT2296686E/pt unknown
- 2009-05-21 PT PT171711559T patent/PT3225250T/pt unknown
- 2009-05-21 DK DK13181216.6T patent/DK2712622T3/en active
- 2009-05-21 LT LTEP13181216.6T patent/LT2712622T/lt unknown
- 2009-05-21 HU HUE17171152A patent/HUE041370T2/hu unknown
- 2009-05-21 DK DK09751584.5T patent/DK2296686T4/en active
- 2009-05-21 EP EP17171152.6A patent/EP3225249B1/en active Active
- 2009-05-21 HU HUE13181216A patent/HUE030409T2/en unknown
- 2009-05-21 PT PT161658752T patent/PT3085381T/pt unknown
- 2009-05-21 ES ES17171152T patent/ES2710454T3/es active Active
- 2009-05-21 EP EP16165875.2A patent/EP3085381B1/en active Active
- 2009-05-21 EP EP09751584.5A patent/EP2296686B2/en active Active
-
2015
- 2015-03-31 JP JP2015072698A patent/JP6001121B2/ja active Active
-
2016
- 2016-08-22 HR HRP20161066TT patent/HRP20161066T1/hr unknown
- 2016-08-31 JP JP2016169163A patent/JP6258424B2/ja active Active
-
2017
- 2017-01-20 LT LTPA2017001C patent/LTC2712622I2/lt unknown
- 2017-04-12 LU LU00015C patent/LUC00015I2/fr unknown
- 2017-12-06 JP JP2017234382A patent/JP6506821B2/ja active Active
-
2018
- 2018-01-26 US US15/880,697 patent/US20180250357A1/en not_active Abandoned
- 2018-05-17 HR HRP20180774TT patent/HRP20180774T1/hr unknown
-
2019
- 2019-01-18 HR HRP20190114TT patent/HRP20190114T1/hr unknown
- 2019-03-29 JP JP2019067813A patent/JP6836618B2/ja active Active
- 2019-04-26 HU HUS1900024C patent/HUS1900024I1/hu unknown
- 2019-04-30 NO NO2019021C patent/NO2019021I1/no unknown
- 2019-10-14 HR HRP20191854TT patent/HRP20191854T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180774T1 (hr) | Orodisperzibilni dezmopresin za povećanje početnog razdoblja sna neometanog s nokturijom | |
HRP20181026T1 (hr) | Dugodjelujuće formulacije inzulina | |
HRP20160189T1 (hr) | Liječenje crohnove bolesti lakvinimodom | |
HRP20121072T1 (hr) | Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja | |
NZ600544A (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
MX2009012485A (es) | Formulacion oral de nicotina amortiguada con aminoacidos. | |
JP2016505023A5 (hr) | ||
HRP20121033T1 (hr) | Praškasta formulacija za valganciklovir | |
HRP20150120T1 (hr) | Materijal i metode za lijeäśenje poremeä†aja u razvoju ukljuäśujuä†i komorbidni i idiopatski autizam | |
HRP20130123T1 (hr) | Postupak lijeäśenja bolesti | |
JP2016500660A5 (hr) | ||
JP2011520980A5 (hr) | ||
WO2023237124A1 (zh) | 一种藏红花素混悬剂及其在制备快速抗抑郁药物中的应用 | |
HRP20161717T1 (hr) | Nalmefen za smanjenje konzumacije alkohola u specifičnim ciljnim populacijama | |
RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
JP2013523628A5 (hr) | ||
CN101107998A (zh) | 一种改善记忆的保健食品及其制备方法 | |
RU2009145804A (ru) | Аксомадол для лечения боли от артроза | |
KR20130066874A (ko) | 과민성 장 증후군의 예방 또는 치료에 유용한 화합물 및 이를 포함하는 조성물 | |
CN103142504A (zh) | 一种甘糖酯缓释颗粒及其制备方法 | |
WO2016074117A1 (zh) | 一种治疗肾虚的药物组合物及其制备方法 | |
RU2010122438A (ru) | Противовирусное средство для профилактики и лечения клещевого энцефалита | |
CN110693934B (zh) | 治疗类风湿性关节炎的组合物及其应用 | |
CN103142503B (zh) | 一种阿法骨化醇缓释颗粒及其制备方法 | |
JP5565016B2 (ja) | 低体温改善用組成物及び冷え性改善用組成物 |